Kristen K. Buono, None; Mauro T. Leite, None; Christopher Bowd, Pfizer, Inc (F); Robert N. Weinreb, Alcon Laboratories Inc (C), Allergan Inc (C), Carl Zeiss Meditec Inc (F, C), Heidelberg Engineering GmbH (F), Merck Inc (C), Novartis Inc (F), Optovue Inc (F, C), Pfizer Inc (C), Topcon Medical Systems Inc (F); Felipe A. Medeiros, Alcon Laboratories Inc (F, C, R), Allergan Inc (C, R), Carl Zeiss Meditec Inc (F, R), Merck Inc (F), Pfizer Inc (F, C, R), Reichert Inc (R); Christopher A. Girkin, Alcon Laboratories Inc (C), Allergan Inc (C), Carl Zeiss Meditec Inc (R), Heidelberg Engineering GmbH (R), Merck Inc (R), Optive Inc (R), Pfizer Inc (C), Topcon Medical Systems Inc (R); Jeffrey M. Liebmann, Alcon Laboratories Inc (C), Allergan Inc (C), Carl Zeiss Meditec Inc (F), Dyopsis Corp (F, C), Heidelberg Engineering GmbH (F), Optovue Inc (F, C), Pfizer Inc (C), Topcon Medical Systems Inc (F, C); Pamela A. Sample, Carl Zeiss Meditec Inc (F), Haag-Streit Inc (F); Linda M. Zangwill, Carl Zeiss Meditec Inc (F), Heidelberg Engineering GmbH (F, R), Optovue Inc (F), Topcon Medical Systems Inc (F)